{"id":"https://openalex.org/W1532804341","doi":"https://doi.org/10.1128/aac.41.11.2362","title":"Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus","display_name":"Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus","alternate_titles":[],"publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W1532804341","doi":"https://doi.org/10.1128/aac.41.11.2362","mag":"1532804341","pmid":"https://pubmed.ncbi.nlm.nih.gov/9371334","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/164129"},"language":"en","primary_location":{"id":"doi:10.1128/aac.41.11.2362","doi":"https://doi.org/10.1128/aac.41.11.2362","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.41.11.2362","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1532804341"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC164129","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114248321","display_name":"M Tanaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Tanaka","raw_affiliation_strings":["New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073370335","display_name":"Yoshikuni Onodera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y Onodera","raw_affiliation_strings":["New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y Uchida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y Uchida","raw_affiliation_strings":["New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109865497","display_name":"Kenichi Sato","orcid":"https://orcid.org/0000-0003-0446-8017","observed_orcids":["https://orcid.org/0000-0003-0446-8017"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K Sato","raw_affiliation_strings":["New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036807748","display_name":"Isao Hayakawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I Hayakawa","raw_affiliation_strings":["New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.5298,"has_fulltext":false,"cited_by_count":79,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97575279,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"41","issue":"11","first_page":"2362","last_page":"2366"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.8690999746322632,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.8690999746322632,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.11479999870061874,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinolones","display_name":"quinolones","score":0.9729999899864197},{"id":"https://openalex.org/keywords/topoisomerase-iv","display_name":"topoisomerase IV","score":0.9139999747276306},{"id":"https://openalex.org/keywords/dna-gyrase","display_name":"DNA gyrase","score":0.9750000238418579},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quinolone-resistance","display_name":"quinolone resistance","score":0.7450000047683716},{"id":"https://openalex.org/keywords/grla","display_name":"grlA","score":0.7049999833106995},{"id":"https://openalex.org/keywords/levofloxacin","display_name":"levofloxacin","score":0.7870000004768372},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":0.921999990940094},{"id":"https://openalex.org/keywords/sparfloxacin","display_name":"sparfloxacin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tosufloxacin","display_name":"tosufloxacin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/supercoiling","display_name":"supercoiling","score":0.5180000066757202},{"id":"https://openalex.org/keywords/amino-acid-substitutions","display_name":"amino acid substitutions","score":0.5889999866485596},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C167125095","wikidata":"https://www.wikidata.org/wiki/Q70551687","display_name":"DNA gyrase","level":4,"score":0.9703106880187988},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.8014655113220215},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.7251341938972473},{"id":"https://openalex.org/C2777112418","wikidata":"https://www.wikidata.org/wiki/Q7824976","display_name":"Topoisomerase IV","level":5,"score":0.694869875907898},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6402027606964111},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5184149742126465},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.507590651512146},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.4801703989505768},{"id":"https://openalex.org/C2779922871","wikidata":"https://www.wikidata.org/wiki/Q426549","display_name":"Quinolone","level":3,"score":0.45627421140670776},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4341461658477783},{"id":"https://openalex.org/C2778049240","wikidata":"https://www.wikidata.org/wiki/Q411447","display_name":"Ofloxacin","level":4,"score":0.41796430945396423},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.37308967113494873},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32374751567840576},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.3031625747680664},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.25815704464912415},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.18083110451698303},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15607473254203796},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12470236420631409},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0936148464679718}],"mesh":[{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D027101","descriptor_name":"DNA Topoisomerase IV","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.41.11.2362","doi":"https://doi.org/10.1128/aac.41.11.2362","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.41.11.2362","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:149263","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC164129","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:164129","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC164129/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:9371334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9371334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:149263","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC164129","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309773","display_name":"Japan Health Sciences Foundation","ror":"https://ror.org/04z7xfj55"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1845297809","https://openalex.org/W1995079580","https://openalex.org/W2003653106","https://openalex.org/W2073866269","https://openalex.org/W2098189336","https://openalex.org/W2100467222","https://openalex.org/W2109816570","https://openalex.org/W2115701502","https://openalex.org/W2126255056","https://openalex.org/W2127076623","https://openalex.org/W2143683338","https://openalex.org/W2149941941","https://openalex.org/W2153547769","https://openalex.org/W2154806021","https://openalex.org/W2160564307","https://openalex.org/W2164175455","https://openalex.org/W2167862584","https://openalex.org/W4241841228"],"related_works":["https://openalex.org/W2149941941","https://openalex.org/W2160564307","https://openalex.org/W2100467222","https://openalex.org/W2032558281","https://openalex.org/W1826075391","https://openalex.org/W2133125702","https://openalex.org/W2164175455","https://openalex.org/W2009621302","https://openalex.org/W1997755659"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,124,199],"clarify":[3],"the":[4,59,131,140,186,206,213,216],"mechanism":[5],"of":[6,8,17,56,62,81,93,118,143,152,158,173,183],"action":[7],"quinolones":[9,57,145,184],"against":[10,90,185,205],"Staphylococcus":[11],"aureus,":[12],"GrlA":[13],"and":[14,45,88,105,109],"GrlB":[15],"proteins":[16,32,157],"topoisomerase":[18,63,91,147,159,187],"IV":[19,64,92,148,160,188],"encoded":[20],"by":[21,67],"genes":[22,218],"with":[23,33,70,113],"or":[24,167,175],"without":[25],"mutations":[26,214],"were":[27,65,98,110,121,177,196],"purified":[28],"separately":[29],"as":[30,73],"fusion":[31],"maltose-binding":[34],"protein":[35],"in":[36,149,215],"Escherichia":[37],"coli.":[38],"The":[39,53,76,116,180],"reconstituted":[40],"enzymes":[41],"showed":[42],"ATP-dependent":[43],"decatenation":[44,60],"relaxing":[46],"activities":[47,182],"but":[48],"had":[49],"no":[50],"supercoiling":[51],"activity.":[52],"inhibitory":[54,78,181],"effects":[55],"on":[58],"activity":[61],"determined":[66],"quantitative":[68],"electrophoresis":[69],"kinetoplast":[71],"DNA":[72,132],"a":[74,191],"substrate.":[75],"50%":[77],"concentrations":[79],"(IC50s)":[80],"levofloxacin,":[82],"DR-3354,":[83],"DU-6859a,":[84],"DV-7751a,":[85],"ciprofloxacin,":[86],"sparfloxacin,":[87],"tosufloxacin":[89],"S.":[94,153],"aureus":[95],"FDA":[96],"209-P":[97],"2.3,":[99],"97,":[100],"0.45,":[101],"1.5,":[102],"2.5,":[103],"7.4,":[104],"1.8":[106],"microg/ml,":[107],"respectively,":[108],"correlated":[111],"well":[112],"their":[114],"MICs.":[115],"IC50s":[117],"these":[119],"drugs":[120],"from":[122,197],"2":[123],"20":[125],"times":[126,201],"lower":[127],"than":[128,203],"those":[129,204],"for":[130],"gyrase.":[133],"These":[134,209],"results":[135,210],"support":[136],"genetic":[137],"evidence":[138],"that":[139,212],"primary":[141],"target":[142],"new":[144],"is":[146],"quinolone-susceptible":[150],"strains":[151],"aureus.":[154],"Three":[155],"altered":[156],"containing":[161],"Ser-->Phe":[162],"changes":[163,169],"at":[164,170],"codon":[165,171],"80":[166],"Glu-->Lys":[168],"84":[172],"grlA,":[174],"both,":[176],"also":[178],"purified.":[179],"which":[189],"contained":[190],"single":[192],"amino":[193],"acid":[194],"change":[195],"8":[198],"95":[200],"weaker":[202],"nonaltered":[207],"enzyme.":[208],"suggest":[211],"corresponding":[217],"confer":[219],"quinolone":[220],"resistance.":[221]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1532804341","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
